A Phase II study assessing Long-Term Response to Ibrutinib Monotherapy in recurrent or refractory CNS Lymphoma.
Christian GrommesSubhiksha NandakumarLauren R SchaffIgor GavrilovicThomas J KaleyCraig P NolanJacqueline B StoneAlissa A ThomasSarah S TangJulia WolfeAlexis BozzaVenissala WongchaiAllison HydeEmma BarrettElizabeth A LynchJuli T MadzsarAndrew L LinAnna F PiotrowskiElena PentsovaJasmine H FrancisVaios HatzoglouNikolaus SchultzAnne S ReinerKatherine S PanageasLisa M DeAngelisIngo K MellinghoffPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
NCT02315326.